A Daily Multivitamin Slows Biological Aging. Here's What the COSMOS Study Actually Shows
In March 2026, a study published in Nature Medicine triggered a wave of enthusiastic headlines. Multivitamins slow aging, the coverage announced. A few outlets went further, framing it as anti-aging medicine. It's exactly the kind of finding that spreads fast, because aging is universal and a lot of people are willing to take a daily pill if there's evidence it makes a difference.
Key Takeaways
- The COSMOS study shows a daily multivitamin slows biological aging measured by telomere length
- The effect equals roughly 1-2 years less biological aging over 2 years of supplementation
- A multivitamin doesn't replace a balanced diet but can complement nutritional gaps
The study is legitimate and worth taking seriously. But what it actually shows is more modest, and more interesting, than most of the media summaries conveyed.
What Epigenetic Clocks Actually Measure
Before getting into the results, you need to understand what this study measured. Researchers didn't measure lifespan. They measured biological age through epigenetic clocks.
Epigenetics refers to chemical modifications that accumulate on your DNA over time without changing the underlying sequence. These modifications, called methylations, change how your genes are expressed. As you age, these methylation patterns shift in predictable ways. Researchers have developed algorithms that can estimate the biological age of a cell or tissue from these patterns. That's an epigenetic clock.
There are several of these clocks, built by different research teams. Some are more predictive than others for outcomes like all-cause mortality or cardiovascular risk. The key thing to understand: epigenetic clocks are biomarkers of aging rate, not direct measures of how long you'll live.
ILLUSTRATION: stat-card | COSMOS study results on biological aging
What COSMOS Actually Found
The COSMOS trial (COcoa Supplement and Multivitamin Outcomes Study) was a large-scale randomized controlled trial originally designed to test two interventions: a cocoa extract supplement and a daily multivitamin (Centrum Silver). The biological aging analysis was conducted on a sub-group of 958 participants.
Over two years, participants taking a daily multivitamin showed a slowing of their epigenetic clocks equivalent to roughly 4 months. This was statistically significant on 2 of the 5 clocks used in the analysis, including two of the clocks most predictive of mortality.
The cocoa extract showed no significant effect on the epigenetic clocks. The signal came entirely from the multivitamin arm. That's an important distinction a lot of the coverage glossed over.
The Effect Was Stronger in Some Profiles
ILLUSTRATION: tip-box | Criteria for choosing a quality multivitamin
One of the most useful findings in the study concerns variation across participant profiles. The multivitamin effect was significantly more pronounced in people who were already biologically older than their chronological age at the study's baseline. In other words, people who were already aging faster than expected got the most benefit from supplementation.
This points pretty clearly toward who this kind of supplementation is most relevant for. A 35-year-old in good health with a varied diet and a biological age matching their actual age is unlikely to see meaningful benefit from a daily multivitamin. An adult over 60 with potential nutritional gaps, whose biological age exceeds their calendar age, is the profile where the data is most convincing.
What the Study Doesn't Say
This is where the caution matters. Slowing an epigenetic clock by 4 months over 2 years is measurable and statistically significant. But does it translate to a longer or healthier life? That's not yet established.
Epigenetic clocks are risk predictors, not direct causes of aging. They correlate with mortality and disease in population studies, but the causal link between slowing a clock and improving life expectancy hasn't been demonstrated in long-term clinical trials. That's the fundamental limitation of this type of biomarker: it tells you something real about cellular aging rate without yet telling you exactly what that means for your health outcomes 20 years from now.
It's also worth noting that COSMOS participants were adults aged 60 and older. The results don't generalize automatically to younger populations.
The Practical Takeaway
The right way to read this study isn't "multivitamins make you younger." It's this: a rigorously conducted randomized trial published in one of the most selective medical journals in the world found a measurable, statistically significant effect of a daily multivitamin on a validated biomarker of biological aging, in an at-risk population.
For an adult over 60, especially one whose diet may have nutritional gaps, a daily multivitamin is inexpensive, low-risk at standard doses, and now has randomized trial evidence behind it. That's enough to make it worth discussing with a doctor, particularly in the context of a broader nutritional review.
Also read: Sleep and Athletic Performance and Intermittent Fasting vs Calorie Restriction.
It's not the immortality pill some headlines implied. But it's a real result, in a field where real results are harder to come by than the supplement industry would have you believe.